Is it time to buy Medibank Private Ltd, SEEK Limited and REA Group Limited?

Medibank Private Ltd (ASX:MPL), SEEK Limited (ASX:SEK) and REA Group Limited (ASX:REA) are all trading near their 52-week lows.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the fun ways to spend breakfast on a Saturday morning (OK, this isn't everyone's idea of fun) is to scour through the share tables searching for stock ideas that could be worth further investigation.

Without a doubt, my favourite columns are the 52-week low and high columns with a particular emphasis on new highs and new lows. While I'm naturally drawn to the 'low' column for unloved and oversold bargains, there is equally likely to be a great stock with wonderful potential that could still be a great purchase basking in the spotlight of a 'new high' column.

Three leading industrial stocks that are trading near their 52-week lows and could be worth investigating further are Medibank Private Ltd (ASX:MPL), SEEK Limited (ASX:SEK) and REA Group Limited (ASX:REA).

Here's how they are currently priced based on earnings per share (EPS) data provided by Morningstar compared to the S&P/ASX 300 (Index: ^AXKO) (ASX: XKO), which is on a financial year (FY) 2015 price-to-earnings (PE) multiple of 18.2x.

  • Medibank Private: Share price $2.22; 52-week low $2.08; EPS 9.7 cents per share (cps); PE 22.9x
  • SEEK: Share price $16.60; 52-week low $15.17; EPS 58.6 cps; PE 28.3x
  • REA Group: Share price $41.94; 52-week low $39.45; EPS 145.3 cps; PE 28.9x

Even though each of these stocks is trading near their yearly lows, their multiples are still high compared with the overall market. That could well be justified given the above average EPS growth forecast for these three companies in FY 2016. While the index is expected to record EPS growth of just 7.4% in FY 2016, Medibank, SEEK and REA are forecast to produce EPS growth of 12%, 21.7% and 24.1% respectively, which could make the current share price weakness a buying opportunity for long-term investors.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »